glp 1 renal impairment GLP-1 Receptor Agonists and Kidney Protection glp-1 and kidney disease Mechanisms
Description
This review summarizes current evidence on the nutritional implications of GLP1-based pharmacotherapy in adults with obesity, including common gastrointestinal adverse events, reduced energy intake, potential macro and micronutrient inadequacies, and risks of lean mass loss
Discover how CGM insights help monitor glucose patterns during the transition.
Heres what to check before starting GLP-1 treatment.
Chef Anne Burrell dies at 55
